Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NVO Novo Nordisk A S	$198B	$21.6 Million 0.2% of portfolio	181,470	Q3 2024 Reduced 4.22%
VRTX Vertex Pharmaceuticals Inc	$105B	$20.8 Million 0.2% of portfolio	44,756	Q3 2024 Added 10.02%
VKTX Viking Therapeutics, Inc.	$3.29B	$10 Million 0.09% of portfolio	158,051	Q3 2024 Added 21.65%
RNA Avidity Biosciences, Inc.	$1.59B	$4.3 Million 0.04% of portfolio	93,618	Q3 2024 Reduced 9.28%
REGN Regeneron Pharmaceuticals, Inc.	$77B	$3.83 Million 0.04% of portfolio	3,646	Q3 2024 Added 4.56%
APLS Apellis Pharmaceuticals, Inc.	$3.68B	$3.25 Million 0.03% of portfolio	112,795	Q3 2024 Added 37.89%
CRMD Cor Medix Inc.	$337M	$1.18 Million 0.01% of portfolio	146,613	Q3 2024 Added 2.74%
ETNB 89bio, Inc.	$369M	$594,000 0.01% of portfolio	80,360	Q3 2024 Added 42.02%
CORT Corcept Therapeutics Inc	$5.45B	$560,000 0.01% of portfolio	12,112	Q3 2024 Reduced 50.97%
MIRM Mirum Pharmaceuticals, Inc.	$1.57B	$337,000 0.0% of portfolio	8,664	Q3 2024 Reduced 75.83%
MRNA Moderna, Inc.	$16.5B	$317,000 0.0% of portfolio	4,746	Q3 2024 Reduced 7.36%
BPMC Blueprint Medicines Corp	$5.28B	$309,000 0.0% of portfolio	3,351	Q3 2024 Added 28.39%
RGNX Regenxbio Inc.	$336M	$276,000 0.0% of portfolio	26,363	Q3 2024 Reduced 5.38%
ALNY Alnylam Pharmaceuticals, Inc.	$28.8B	$247,000 0.0% of portfolio	900	Q3 2024 Added 1.12%
ADMA Adma Biologics, Inc.	$3.62B	$228,000 0.0% of portfolio	11,428	Q3 2024 Added 1,042.8%
ARGX Argenx Se	$34.4B	$195,000 0.0% of portfolio	360	Q3 2024 Reduced 1.1%
UTHR United Therapeutics Corp	$16.2B	$186,000 0.0% of portfolio	520	Q3 2024 Added 1,233.33%
EXEL Exelixis, Inc.	$10.9B	$174,000 0.0% of portfolio	6,720	Q3 2024 Added 83.81%
MNKD Mannkind Corp	$1.67B	$172,000 0.0% of portfolio	27,431	Q3 2024 Added 117.24%
BGNE Bei Gene, Ltd.	$19.2B	$156,000 0.0% of portfolio	699	Q3 2024 Reduced 0.71%
RCKT Rocket Pharmaceuticals, Inc.	$951M	$156,000 0.0% of portfolio	8,500	Q3 2024 Added 13.33%
TECH Bio Techne Corp	$2.89B	$149,000 0.0% of portfolio	1,869	Q3 2024 Added 3.03%
ALT Altimmune, Inc.	$356M	$124,000 0.0% of portfolio	20,200	Q3 2024 Added 50.19%
IOVA Iovance Biotherapeutics, Inc.	$1.21B	$95,000 0.0% of portfolio	10,197	Q3 2024 Reduced 7.27%
TGTX Tg Therapeutics, Inc.	$4.37B	$94,000 0.0% of portfolio	4,045	Q3 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$2.91B	$93,000 0.0% of portfolio	1,675	Q3 2024 Added 8.06%
NRIX Nurix Therapeutics, Inc.	$929M	$90,000 0.0% of portfolio	4,050	Q3 2024 New
IONS Ionis Pharmaceuticals Inc	$4.94B	$82,000 0.0% of portfolio	2,055	Q3 2024 Added 226.71%
ARDX Ardelyx, Inc.	$787M	$67,000 0.0% of portfolio	9,728	Q1 2024 Added 462.96%
BMRN Biomarin Pharmaceutical Inc	$12.4B	$65,000 0.0% of portfolio	936	Q3 2024 Reduced 66.58%
INCY Incyte Corp	$15.5B	$55,000 0.0% of portfolio	846	Q3 2024 Reduced 19.04%
BNTX Bio N Tech Se	$28.1B	$44,000 0.0% of portfolio	375	Q3 2024 Added 36.36%
CRSP Crispr Therapeutics Ag	$3.2B	$44,000 0.0% of portfolio	948	Q3 2024 Reduced 16.77%
JAZZ Jazz Pharmaceuticals PLC	$7.56B	$36,000 0.0% of portfolio	327	Q3 2024 Added 8,075.0%
SMMT Summit Therapeutics Inc.	$3.67B	$35,000 0.0% of portfolio	1,603	Q3 2024 New
EXAI Exscientia PLC	$593M	$31,000 0.0% of portfolio	6,521	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$922M	$31,000 0.0% of portfolio	1,530	Q3 2024 Reduced 34.73%
RXRX Recursion Pharmaceuticals, Inc.	$1.41B	$30,000 0.0% of portfolio	4,583	Q3 2024 Added 189.51%
HALO Halozyme Therapeutics, Inc.	$6.65B	$29,000 0.0% of portfolio	513	Q3 2024 Added 63.9%
CYTK Cytokinetics Inc	$4.65B	$26,000 0.0% of portfolio	500	Q3 2024 New
NKTX Nkarta, Inc.	$122M	$23,000 0.0% of portfolio	5,300	Q3 2024 New
ORMP Oramed Pharmaceuticals Inc.	$94.7M	$21,000 0.0% of portfolio	8,826	Q1 2024 New
GERN Geron Corp	$1.35B	$18,000 0.0% of portfolio	4,000	Q2 2024 Added 100.0%
INSM Insmed Inc	$9.46B	$18,000 0.0% of portfolio	250	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$531M	$17,000 0.0% of portfolio	2,500	Q3 2024 Added 150.0%
ABUS Arbutus Biopharma Corp	$513M	$15,000 0.0% of portfolio	4,000	Q4 2022 Reduced 20.0%
XLO Xilio Therapeutics, Inc.	$29.9M	$15,000 0.0% of portfolio	20,000	Q3 2024 New
BBIO Bridge Bio Pharma, Inc.	$4.17B	$14,000 0.0% of portfolio	550	Q3 2024 Added 175.0%
SRPT Sarepta Therapeutics, Inc.	$11.1B	$14,000 0.0% of portfolio	118	Q3 2024 Added 136.0%
VERV Verve Therapeutics, Inc.	$374M	$14,000 0.0% of portfolio	3,050	Q3 2024 Reduced 30.68%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.